These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31813396)

  • 1. No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder.
    Hjorthøj C; Uddin MJ; Wimberley T; Dalsgaard S; Hougaard DM; Børglum A; Werge T; Nordentoft M
    Psychol Med; 2021 Feb; 51(3):479-484. PubMed ID: 31813396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic liability to ADHD and substance use disorders in individuals with ADHD.
    Wimberley T; Agerbo E; Horsdal HT; Ottosen C; Brikell I; Als TD; Demontis D; Børglum AD; Nordentoft M; Mors O; Werge T; Hougaard D; Bybjerg-Grauholm J; Hansen MB; Mortensen PB; Thapar A; Riglin L; Langley K; Dalsgaard S
    Addiction; 2020 Jul; 115(7):1368-1377. PubMed ID: 31803957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls.
    Olesen JA; Posselt CM; Poulsen CH; Nordentoft M; Hjorthøj C
    Psychol Med; 2020 Feb; 50(3):499-506. PubMed ID: 30880659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic risk for psychiatric disorder and singleness in patients with severe mental illness and controls.
    Hjorthøj C; Uddin MJ; Hougaard DM; Sørensen HJ; Nordentoft M
    J Psychiatr Res; 2019 Dec; 119():60-66. PubMed ID: 31563858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric Polygenic Risk Scores as Predictor for Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in a Clinical Child and Adolescent Sample.
    Jansen AG; Dieleman GC; Jansen PR; Verhulst FC; Posthuma D; Polderman TJC
    Behav Genet; 2020 Jul; 50(4):203-212. PubMed ID: 31346826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Polygenic Risk Scores on the Association Between Infections and Schizophrenia.
    Benros ME; Trabjerg BB; Meier S; Mattheisen M; Mortensen PB; Mors O; Børglum AD; Hougaard DM; Nørgaard-Pedersen B; Nordentoft M; Agerbo E
    Biol Psychiatry; 2016 Oct; 80(8):609-16. PubMed ID: 27364036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis.
    Agerbo E; Sullivan PF; Vilhjálmsson BJ; Pedersen CB; Mors O; Børglum AD; Hougaard DM; Hollegaard MV; Meier S; Mattheisen M; Ripke S; Wray NR; Mortensen PB
    JAMA Psychiatry; 2015 Jul; 72(7):635-41. PubMed ID: 25830477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of genetic risk for schizophrenia on eating disorder clinical presentations.
    Zhang R; Kuja-Halkola R; Borg S; Leppä V; Thornton LM; Birgegård A; Bulik CM; Bergen SE
    Transl Psychiatry; 2023 Nov; 13(1):366. PubMed ID: 38030607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings.
    Maxwell JM; Coleman JRI; Breen G; Vassos E
    JAMA Psychiatry; 2021 Dec; 78(12):1355-1364. PubMed ID: 34705035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users.
    Johnson EC; Colbert SMC; Jeffries PW; Tillman R; Bigdeli TB; Karcher NR; Chan G; Kuperman S; Meyers JL; Nurnberger JI; Plawecki MH; Degenhardt L; Martin NG; Kamarajan C; Schuckit MA; Murray RM; Dick DM; Edenberg HJ; D'Souza DC; Di Forti M; Porjesz B; Nelson EC; Agrawal A
    Schizophr Bull; 2023 May; 49(3):778-787. PubMed ID: 36545904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder.
    Jefsen OH; Erlangsen A; Nordentoft M; Hjorthøj C
    JAMA Psychiatry; 2023 Aug; 80(8):803-810. PubMed ID: 37223912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance.
    Meyers JL; Salvatore JE; Aliev F; Johnson EC; McCutcheon VV; Su J; Kuo SI; Lai D; Wetherill L; Wang JC; Chan G; Hesselbrock V; Foroud T; Bucholz KK; Edenberg HJ; Dick DM; Porjesz B; Agrawal A
    Transl Psychiatry; 2019 Oct; 9(1):269. PubMed ID: 31636251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cannabis use disorder and schizophrenia stronger in young males than in females.
    Hjorthøj C; Compton W; Starzer M; Nordholm D; Einstein E; Erlangsen A; Nordentoft M; Volkow ND; Han B
    Psychol Med; 2023 Nov; 53(15):7322-7328. PubMed ID: 37140715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive capacity of psychiatric and psychological polygenic risk scores for distinguishing cases in a child and adolescent psychiatric sample from controls.
    Jansen AG; Jansen PR; Savage JE; Kraft J; Skarabis N; Polderman TJC; Dieleman GC
    J Child Psychol Psychiatry; 2021 Sep; 62(9):1079-1089. PubMed ID: 33825194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the polygenic risk score for schizophrenia with mortality and suicidal behavior - A Danish population-based study.
    Laursen TM; Trabjerg BB; Mors O; Børglum AD; Hougaard DM; Mattheisen M; Meier SM; Byrne EM; Mortensen PB; Munk-Olsen T; Agerbo E
    Schizophr Res; 2017 Jun; 184():122-127. PubMed ID: 27939829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
    Musliner KL; Krebs MD; Albiñana C; Vilhjalmsson B; Agerbo E; Zandi PP; Hougaard DM; Nordentoft M; Børglum AD; Werge T; Mortensen PB; Østergaard SD
    Am J Psychiatry; 2020 Oct; 177(10):936-943. PubMed ID: 32660297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study.
    Nielsen SM; Toftdahl NG; Nordentoft M; Hjorthøj C
    Psychol Med; 2017 Jul; 47(9):1668-1677. PubMed ID: 28166863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of readmission among individuals with cannabis use disorder during a 15-year cohort study: the impact of socio-economic factors and psychiatric comorbidity.
    Rabiee R; Sjöqvist H; Agardh E; Lundin A; Danielsson AK
    Addiction; 2023 Jul; 118(7):1295-1306. PubMed ID: 36746781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study implicates CHRNA2 in cannabis use disorder.
    Demontis D; Rajagopal VM; Thorgeirsson TE; Als TD; Grove J; Leppälä K; Gudbjartsson DF; Pallesen J; Hjorthøj C; Reginsson GW; Tyrfingsson T; Runarsdottir V; Qvist P; Christensen JH; Bybjerg-Grauholm J; Bækvad-Hansen M; Huckins LM; Stahl EA; Timmermann A; Agerbo E; Hougaard DM; Werge T; Mors O; Mortensen PB; Nordentoft M; Daly MJ; Stefansson H; Stefansson K; Nyegaard M; Børglum AD
    Nat Neurosci; 2019 Jul; 22(7):1066-1074. PubMed ID: 31209380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between externalizing disorders polygenic risk scores and contextual factors on the development of marijuana use disorders.
    Rabinowitz JA; Musci RJ; Milam AJ; Benke K; Uhl GR; Sisto DY; Ialongo NS; Maher BS
    Drug Alcohol Depend; 2018 Oct; 191():365-373. PubMed ID: 30195949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.